structural basis west nile virus neutralization therapeutic antibody 
west nile virus mosquito-borne flavivirus closely related human epidemic-causing dengue yellow fever japanese encephalitis viruses1 establishing infection icosahedral viruses undergo endosomal membrane fusion catalysed envelope glycoprotein rearrangement putative receptor-binding domain iii diii exposure hydrophobic fusion loop2- humoral immunity essential protective function early course west nile virus infection56 investigate mechanism neutralization e16 monoclonal antibody specifically binds diii structurally e16 antibody fab fragment engages residues positioned four loops diii consensus neutralizing epitope sequence conserved west nile virus distinct flaviviruses e16 epitope protrudes surface mature virions three distinct environments7 docking studies predict fab binding will leave fivefold clustered epitopes exposed also show e16 inhibits infection primarily step viral attachment potentially blocking envelope glycoprotein conformational changes collectively results suggest vaccine strategy targeting dominant diii epitope may elicit safe effective immune responses flaviviral diseases 
